Stock listing
Processa Pharmaceuticals, Inc.
Selected listing: PCSA · NASDAQ · USD · US
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), Health Technology. Latest release Sep 1, 2026: Processa Pharmaceuticals to Participate in Upcoming Investor…
- Ticker
- NASDAQ:PCSA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Processa Pharmaceuticals, Inc.
The company focuses on developing innovative pharmaceutical products to address unmet medical needs. Processa is committed to advancing its pipeline and contributing to the healthcare sector.
Latest news from Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
September 1, 2026
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
July 29, 2026
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
January 5, 2026
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
December 17, 2025
Events
Research Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. company profile
View the public company page for Processa Pharmaceuticals, Inc. on 6ix.
Processa Pharmaceuticals, Inc. news
Read company news and market updates connected to Processa Pharmaceuticals, Inc..
Processa Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Processa Pharmaceuticals, Inc..